Cargando…

The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam

INTRODUCTION: Bile acid diarrhoea (BAD) is a common disorder that results from an increased loss of primary bile acids and can result in a change in microbiome. The aims of this study were to characterise the microbiome in different cohorts of patients with BAD and to determine if treatment with a b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Aditi, Quraishi, Mohammed Nabil, Al-Hassi, Hafid O., El-Asrag, Mohammed E., Segal, Jonathan P., Jain, Manushri, Steed, Helen, Butterworth, Jeffrey, Farmer, Adam, Mclaughlin, John, Beggs, Andrew, Brookes, Matthew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063896/ https://www.ncbi.nlm.nih.gov/pubmed/37007510 http://dx.doi.org/10.3389/fmicb.2023.1134105

Ejemplares similares

The impact of treatment with bile acid sequestrants on quality of life in patients with bile acid diarrhoea
por: Kumar, Aditi, et al.
Publicado: (2022)

A single faecal bile acid stool test demonstrates potential efficacy in replacing SeHCAT testing for bile acid diarrhoea in selected patients
por: Kumar, Aditi, et al.
Publicado: (2022)

Oral and Intravenous Iron Therapy Differentially Alter the On- and Off-Tumor Microbiota in Anemic Colorectal Cancer Patients
por: Phipps, Oliver, et al.
Publicado: (2021)

Influence of Iron on the Gut Microbiota in Colorectal Cancer
por: Phipps, Oliver, et al.
Publicado: (2020)

Differences in the On- and Off-Tumor Microbiota between Right- and Left-Sided Colorectal Cancer
por: Phipps, Oliver, et al.
Publicado: (2021)

Bile Acids and the Microbiome: Making Sense of This Dynamic Relationship in Their Role and Management in Crohn's Disease
por: Kumar, Aditi, et al.
Publicado: (2022)

Variability in the Pre-Analytical Stages Influences Microbiome Laboratory Analyses
por: Kumar, Aditi, et al.
Publicado: (2022)

COVID-19 vaccinations in patients with inflammatory bowel disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(−/−) mice by modulating composition, signalling and excretion of faecal bile acids
por: Fuchs, Claudia Daniela, et al.
Publicado: (2018)

Role of Colesevelam in Combination Lipid-Lowering Therapy
por: Jones, Michael R., et al.
Publicado: (2013)

Prevention of COVID-19 in patients with IBD
por: Segal, Jonathan P, et al.
Publicado: (2020)

Meta‐analysis of the demographic and prognostic significance of gastrointestinal symptoms in COVID‐19 patients
por: Zaman, Shafquat, et al.
Publicado: (2022)

Safety and Efficacy of Colesevelam HCl in the Treatment of Elderly Patients
por: Gavin, James R., et al.
Publicado: (2014)

Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
por: Hartmann, Phillipp, et al.
Publicado: (2022)

Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70(−/−) Mice with a Human-like Bile Acid Composition
por: Palmiotti, Anna, et al.
Publicado: (2023)

Role of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children
por: Sonnett, Travis, et al.
Publicado: (2010)

The Ferritin, Hepcidin and Cytokines Link in the Diagnoses of Iron Deficiency Anaemia during Pregnancy: A Review
por: Chibanda, Yvonne, et al.
Publicado: (2023)

Postinfective Diarrhoea and Bile Acid Malabsorption
por: Niaz, S K, et al.
Publicado: (1997)

Bile Acid Malabsorption in Persistent Diarrhoea
por: Smith, Michael J, et al.
Publicado: (2000)

A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways
por: Quraishi, Mohammed Nabil, et al.
Publicado: (2020)

Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors
por: Bays, Harold, et al.
Publicado: (2007)

Colesevelam hydrochloride: A novel agent in patients with type 2 diabetes
por: Sekhri, Kavita, et al.
Publicado: (2011)

Atypical Mechanism of Glucose Modulation by Colesevelam in Patients with Type 2 Diabetes
por: Nwose, Oliseyenum M., et al.
Publicado: (2013)

Effectiveness and Tolerability of Colesevelam HCl for Accelerated Elimination of Teriflunomide in Healthy Participants
por: Lunven, Catherine, et al.
Publicado: (2017)

Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
por: Pavlou, Panagiotis, et al.
Publicado: (2021)

Colesevelam Reduces Ethanol-Induced Liver Steatosis in Humanized Gnotobiotic Mice
por: Cabré, Noemí, et al.
Publicado: (2021)

The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease
por: Segal, Jonathan P., et al.
Publicado: (2019)

The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era
por: Quraishi, Mohammed Nabil, et al.
Publicado: (2021)

Bile acid diarrhoea: pathophysiology, diagnosis and management
por: Farrugia, Alexia, et al.
Publicado: (2020)

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
por: Fonseca, Vivian A, et al.
Publicado: (2010)

Effect of Colesevelam HCl Monotherapy on Lipid Particles in Type 2 Diabetes Mellitus
por: Rosenson, Robert S., et al.
Publicado: (2014)

Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development
por: Zhou, Enchen, et al.
Publicado: (2020)

The pathophysiology of bile acid diarrhoea: differences in the colonic microbiome, metabolome and bile acids
por: Sagar, Nidhi M., et al.
Publicado: (2020)

An urgent need to institute COVID-19 testing in patients with IBD experiencing flares
por: Quraishi, Mohammed Nabil, et al.
Publicado: (2020)

Real-world utilization patterns and outcomes of colesevelam hcl in the ge electronic medical record
por: Hansen, Richard A, et al.
Publicado: (2013)

Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis
por: Rees, Nia Paddison, et al.
Publicado: (2022)

Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease
por: Yalchin, Mehmet, et al.
Publicado: (2019)

Application of a Novel Tool for Diagnosing Bile Acid Diarrhoea
por: Covington, James A., et al.
Publicado: (2013)

Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam – a clinical perspective
por: Goldberg, Ronald B
Publicado: (2009)

High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria
por: Shiha, Mohamed G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0i6fc72vm94vmud9i8o5f082su